Skip to main content
OpenTrials

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

354 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Neuroblastoma trial results

Completed

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

NCT01059071

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
View Trial Details
Completed

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma

NCT00601003

Conditions
Glioma, Medulloblastoma, Neoplasms, +9 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States
  • Kapiolani Medical Center for Women and Children Honolulu, Hawaii, United States
View all 15 locations
View Trial Details
Completed

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma

NCT01355679

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
View Trial Details
Completed

Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer

NCT01802567

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumors, +18 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States
View all 13 locations
View Trial Details
Completed

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

NCT00867568

Conditions
Disease Attributes, Glioma, Medulloblastoma, +14 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States
  • Cardinal Glennon Children's Medical Center St Louis, Missouri, United States
  • Levine Children's Hospital Charlotte, North Carolina, United States
View Trial Details
Completed

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

NCT02395666

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
View all 22 locations
View Trial Details

Related conditions